Centrally administered atriopeptin III reduces water intake and vasopressin secretion in dehydrated sheep.
Two experiments were carried out to investigate the responses of sheep (N = 6) to intracerebroventricular (ICV) injections of atriopeptin III [atrial natriuretic factor (5-28), AP III]. In Experiment, 1, 24-h dehydrated animals were given 0 (saline vehicle control), 10 or 30 micrograms AP III directly before the presentation of water. The highest dose of AP III significantly (p less than 0.02) reduced the amount of water drunk in the subsequent 20 min. In Experiment 2, blood samples were taken at various intervals before and after ICV injection of 0 or 30 micrograms AP III when the sheep were water replete or 24-h dehydrated. Plasma concentrations of vasopressin (AVP) and cortisol were measured and estimates were made of plasma osmolality. In the dehydration condition, AVP levels were somewhat reduced (p less than 0.059) after AP III administration but no decrease was observed when the animals were euhydrated. No significant changes in plasma osmolality or cortisol concentrations were observed in response to AP III or the saline vehicle. Because a large dose of AP III (30 micrograms ICV) was required to produce the comparatively small behavioral and endocrine effects observed in this study, the results are suggestive of a pharmacological, rather than a physiological, action of the peptide in this species.
Matthews
S G
SG
AFRC Institute of Animal Physiology and Genetics Research, Cambridge Research Station, England.
Parrott
R F
RF
D000818:Animals; D009320:Atrial Natriuretic Factor / Q000502:physiology*; D003681:Dehydration / Q000097:blood / Q000503:physiopathology*; D004326:Drinking / Q000502:physiology*; D006854:Hydrocortisone / Q000097:blood*; D007276:Injections, Intraventricular; D009994:Osmolar Concentration; D010446:Peptide Fragments; D012756:Sheep; D014667:Vasopressins / Q000378:metabolism*
D010446:Peptide Fragments; D014667:Vasopressins; C062525:atrial natriuretic factor prohormone (103-126); D009320:Atrial Natriuretic Factor; D006854:Hydrocortisone